Top Markets
#1 Cortex Cortex +173.85%
#2 GEKKO GEKKO +52.86%
#3 Audiera Audiera +20.07%
#4 ADO Protocol ADO Protocol +17.27%
#5 Seeker Seeker +16.11%
#6 o1.exchange o1.exchange +12.87%
#7 Status Status +9.82%
#8 OpenGradient OpenGradient +9.53%
#9 Pons Pons +9.24%
#10 Helium Helium +8.90%
Coin of the day
Cortex Cortex
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Classificação em ações #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Preço da ação
$59.98
Última sincronização: 2024-12-13
Valor de mercado
$1.22B
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Longboard Pharmaceuticals, Inc. (LBPH)

Categoria

Healthcare
EPS de Longboard Pharmaceuticals, Inc. (LBPH)
EPS em September 2024 TTM: $-2.24
De acordo com os últimos relatórios financeiros e o preço das ações da Longboard Pharmaceuticals, Inc., o EPS atual da empresa (TTM) é $-2.24. No final de 2022, a empresa teve um EPS de $-2.51, um aumento em relação a ao EPS de 2021, que foi de $-1.62.
Histórico de EPS da Longboard Pharmaceuticals, Inc. de 2020 até 2026
EPS no final de cada ano
Ano EPS Alterar
2026 (TTM) $-2.24 -6.28%
2023 $-2.39 -4.78%
2022 $-2.51 54.94%
2021 $-1.62 97.56%
2020 $-0.82 0.00%
EPS de empresas semelhantes ou concorrentes
Empresa EPS Diferença de EPS País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -873.21%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -1,338.39%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 136.16%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 256.25%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH